Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neurotrophic receptor tyrosine kinase (TRK) family consists of TrkA, TrkB, and TrkC, which are high-affinity receptors for neurotrophins. These receptors play crucial roles in the development, function, and maintenance of the nervous system. Upon ligand binding, TRKs dimerize and autophosphorylate, activating downstream pathways like RAS/MAPK and PI3K/Akt, influencing neuronal survival, differentiation, and synaptic plasticity. Dysregulation or mutations involving NTRK genes, particularly gene fusions, can drive oncogenesis in various cancers. They interact with other molecules such as NCAMs further modulating neurite outgrowth.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophic Receptor Tyrosine Kinase Family (TRK).